医疗设备比例阀市场：按阀门类型、驱动方式、流量、应用和最终用户划分－2026-2032年全球预测

预计到 2025 年，医疗设备比例阀市场价值将达到 14.1 亿美元，到 2026 年将成长至 16.1 亿美元，到 2032 年将达到 37.5 亿美元，复合年增长率为 14.97%。

主要市场统计数据
基准年 2025	14.1亿美元
预计年份：2026年	16.1亿美元
预测年份 2032	37.5亿美元
复合年增长率 (%)	14.97%

比例阀如何重新定义医疗设备中的精确流体控制，并在临床环境中建立新的性能标准。

比例阀在现代医疗设备设计中扮演着日益重要的角色，其对流体、气体和压力的精确控制能够显着提升患者照护并提高器械可靠性。致动器技术和控制电子技术的进步，使得人们对比例阀的反应速度、可重复性和与封闭回路型临床系统的整合度提出了更高的要求。随着临床操作对精度要求的不断提高，以及监管机构对安全性和可追溯性的日益重视，比例阀的功能定位正从单纯的组件转变为系统级的关键部件。

数位化整合、更严格的法规以及跨学科工程的融合正在重塑比例阀领域，带来变革性的变化。

在比例阀领域，技术、监管和商业性等多个方面正同时发生变革性的变化。数位控制架构的引入正将阀门从类比致动器转向网实整合元件，从而实现软体驱动的校准、远距离诊断和自适应控制迴路，进而提高临床响应速度。同时，材料科学的微型化和进步使得阀门能够在保持生物相容性和耐灭菌性的前提下，整合到更小的尺寸中。

2025 年美国关税变动对医疗阀门製造商的供应链、筹资策略和零件冗余的累积影响。

美国2025年实施的关税调整政策对比例阀生产和分销的供应链产生了实际的影响。某些进口零件的成本差异导致製造商重新评估零件筹资策略，迫使他们审查材料清单（BOM）分配、近岸外包机会以及供应商合约条款，以维持成本的可预测性。某些进口子零件成本压力的增加也影响了策略供应商的议价动态，促使他们签订包含风险分担条款和联合库存缓衝的长期合约。

将阀门类型、应用领域、操作模式、最终用户环境和流量等级与临床性能联繫起来的实用細項分析。

以细分市场为中心的观点阐明了设计意图、临床背景和最终用户环境如何影响比例阀的技术和商业性决策。根据阀门类型，设计团队通常区分流量控制阀、减压阀和安全阀，每种阀门都有不同的性能优先级，例如线性度、响应时间和过压特性。这些功能差异会影响材料选择、控制演算法的复杂性和检验通讯协定，进而决定临床环境中需要缓解的故障模式类型。

区域趋势和优先事项（北美和南美、欧洲、中东和非洲、亚太地区）影响分销选择和监管一致性。

区域趋势对比例阀调节技术的研发时机、供应商生态系统、临床导入路径均有显着影响。在美洲，采购週期中，供应弹性、临床证据包和交易透明度往往是优先考虑的因素，这使得能够展现出健全的品质系统、快速技术支援和可靠物流的供应商更具优势。而在欧洲、中东和非洲，通常要求严格遵守当地法规结构并提供统一的技术文檔，这迫使供应商维护全面的合规记录并投资于上市后监测能力。

领先比例阀开发公司的竞争资讯：重点关注产品差异化、供应弹性、策略伙伴关係和生命週期支援。

比例阀开发或整合企业之间的竞争取决于它们能否将技术差异化、运行可靠性和可扩展的支援相结合。主要企业强调精确控制、低功耗驱动方案以及符合无菌和生物相容性要求的检验材料。同样重要的是，供应商能否提供详细的技术资料包、软体介面和长期生命週期支持，这可以减轻原始设备製造商 (OEM) 的整合负担，并最大限度地减少监管方面的阻力。

关键的营运、采购和研发倡议，旨在帮助医疗设备领导者快速将创新的比例阀技术整合到临床产品中。

产业领导者必须将技术知识转化为具体的营运和策略行动，以确保临床部署和商业性永续性。首先，透过制定跨职能需求规范，使工程规范与优先临床应用案例保持一致，这些规范应纳入临床医师、采购部门和品质保证部门的意见。这可以减少后期重新设计，并加快检验。其次，透过对关键组件实施双源采购或经认证的第二供应商策略，并透过快速认证通讯协定儘早检验替代方案，从而降低对单一供应商的依赖风险。

结合技术检验、相关人员访谈和供应链追踪的稳健混合调查方法，确保了准确性和可操作的见解。

本分析的调查方法结合了多种混合方法，以确保技术严谨性和实际应用价值。作为初步调查，我们对设备工程师、临床技术人员、采购经理和法规遵循专家进行了结构化访谈，以了解实际应用中的性能要求、检验挑战和采购重点。此外，我们还对具有代表性的阀门结构进行了技术评估，包括操作机制、控制电子元件、材料相容性和失效模式分析。

整合策略需求和技术方向，指导比例阀的采购、开发和监管合规。

技术、监管和商业性观点的整合揭示了比例阀领域相关人员通用的一系列关键挑战。精确控制、临床环境中可重复的性能以及合规性文件是製造商和原始设备製造商 (OEM) 必须满足的核心技术要求。同时，供应链的稳定性、模组化整合能力和售后支援决定了阀门平台在不同医疗环境中的商业性可行性。

目录

第一章：序言

第二章：调查方法

• 调查设计
• 研究框架
• 市场规模预测
• 数据三角测量
• 调查结果
• 调查的前提
• 研究限制

第三章执行摘要

• 首席主管观点
• 市场规模和成长趋势
• 2025年市占率分析
• FPNV定位矩阵，2025
• 新的商机
• 下一代经营模式
• 产业蓝图

第四章 市场概览

• 产业生态系与价值链分析
• 波特五力分析
• PESTEL 分析
• 市场展望
• 上市策略

第五章 市场洞察

• 消费者洞察与终端用户观点
• 消费者体验基准
• 机会映射
• 分销通路分析
• 价格趋势分析
• 监理合规和标准框架
• ESG与永续性分析
• 中断和风险情景
• 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：医疗设备比例阀市场－阀型

• 流量控制
• 减压
• 压力释放

第九章：医疗设备比例阀市场－依操作方式划分

• 电的
• 气动驱动

第十章：按流量分類的医疗设备比例阀市场

• 0-100 公升/分钟
• 100-500 公升/分钟
• 超过 500 公升/分钟

第十一章：医疗设备比例阀市场：依应用领域划分

• 点滴帮浦
  • 注射器
  • 正位移
• 病患监测
  • 侵入性
  • 非侵入性
• 手术机器人
• 人工呼吸器
  • Icu
  • 携带式的

第十二章：医疗设备比例阀市场：依最终用户划分

• 诊所
  • 全科
  • 专业医疗护理
• 居家医疗
• 医院
  • 私人的
  • 民众

第十三章：医疗设备比例阀市场：依地区划分

• 北美洲和南美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十四章：医疗设备比例阀市场：依类别划分

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十五章：医疗设备比例阀市场：依国家划分

• 我们
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十六章：美国医疗设备比例阀市场

第十七章：中国医疗设备比例阀市场

第十八章 竞争情势

• 市场集中度分析，2025年
  • 浓度比（CR）
  • 赫芬达尔-赫希曼指数 (HHI)
• 近期趋势及影响分析，2025 年
• 2025年产品系列分析
• 基准分析，2025 年
• Beko Technologies AS
• Bosch Rexroth AG
• Burkert Werke GmbH & Co. KG
• Danfoss A/S
• Eaton Corporation plc
• Emerson Electric Co.
• Festo SE & Co. KG
• IMI PLC
• Moog Inc.
• Parker Hannifin Corporation
• Siemens Healthineers AG
• SMC Corporation

The Proportional Valves for Medical Devices Market was valued at USD 1.41 billion in 2025 and is projected to grow to USD 1.61 billion in 2026, with a CAGR of 14.97%, reaching USD 3.75 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 1.41 billion
Estimated Year [2026]	USD 1.61 billion
Forecast Year [2032]	USD 3.75 billion
CAGR (%)	14.97%

How proportional valves are redefining precision fluid control in medical devices and setting new performance expectations across clinical environments

Proportional valves increasingly occupy a pivotal role in modern medical device design, where nuanced control of fluid, gas, and pressure delivers measurable benefits for patient care and device reliability. Advances in actuator technologies and control electronics have elevated expectations for responsiveness, repeatability, and integration with closed-loop clinical systems. As clinical procedures demand finer precision and regulatory authorities require demonstrable safety and traceability, the functional profile of proportional valves has shifted from a component to a system-level enabler.

Design teams now prioritize valves that support deterministic control, low hysteresis, and predictable aging under sterilization and cyclic loads. At the same time, purchasing and operations functions weigh manufacturability, reproducibility, and logistics when selecting valve partners. This intersection of technical and commercial criteria creates new imperatives for cross-disciplinary coordination during product development, validation, and post-market vigilance.

Consequently, stakeholders across engineering, clinical affairs, and supply chain must align specifications, test protocols, and supplier engagement strategies earlier in the product lifecycle. This alignment reduces integration risk, shortens qualification timelines, and helps ensure that device performance objectives translate into reproducible clinical outcomes. The following sections unpack the shifts, segmentation perspectives, regional nuances, competitive dynamics, and recommended actions necessary to navigate this changing landscape with confidence.

Transformative shifts reshaping the proportional valve landscape driven by digital integration, regulatory rigor, and cross-disciplinary engineering convergence

The proportional valve landscape is undergoing multiple transformative shifts that are simultaneously technological, regulatory, and commercial. Digitally enabled control architectures are moving valves from analog actuators to cyber-physical elements, enabling software-driven calibration, remote diagnostics, and adaptive control loops that improve clinical responsiveness. Concurrently, miniaturization and material science advances are allowing valves to be integrated into smaller form factors while maintaining biocompatibility and sterilization resilience.

Regulatory focus has intensified on traceability, software lifecycle management, and human factors, prompting device manufacturers to demand greater documentation and verifiable validation from valve suppliers. This has accelerated strategic partnerships between valve developers and clinical OEMs, where co-development and shared validation plans de-risk integration and align timelines. From a supply perspective, rising emphasis on resilience has led to diversified sourcing strategies and emphasis on qualification of alternate vendors and second-source readiness.

At the same time, clinical practice trends-such as the growth of remote monitoring, expansion of home healthcare, and the increasing use of robotic-assisted procedures-are changing functional requirements. Valves must now perform reliably across a wider set of use cases and environmental conditions while interfacing seamlessly with digital health platforms. Taken together, these shifts demand that engineering, regulatory, and commercial teams rethink specifications, testing regimes, and supplier relationships to maintain competitive and clinical advantage.

Cumulative implications of United States tariff changes in 2025 on supply chains, sourcing strategies, and component redundancy for medical valve manufacturers

Tariff adjustments instituted by United States policy in 2025 have introduced tangible implications for the supply chains that underpin proportional valve production and distribution. Component sourcing strategies are under renewed scrutiny as cost differentials emerge for certain imported parts, prompting manufacturers to reassess BOM allocations, nearshoring opportunities, and supplier contractual terms to preserve cost predictability. The increased cost pressure on specific imported subcomponents has also affected negotiation dynamics with strategic suppliers, motivating longer-term agreements that include shared risk provisions and joint inventory buffering.

Beyond direct input cost impacts, tariff shifts have encouraged manufacturers to revisit their qualification procedures for alternate vendors and expedite validation pathways for domestically sourced or tariff-exempt components. Procurement teams are prioritizing dual-sourcing and capacity audits to mitigate the risk of supply interruptions. At the same time, engineering organizations are exploring design adaptations that reduce dependency on affected components without compromising clinical performance or regulatory compliance, thereby preserving device safety and functionality.

Manufacturers with vertically integrated supply models or diversified supplier ecosystems experience more predictable outcomes, while those with concentrated supplier exposure face higher cadence of commercial and technical remediation. In all cases, the practical response has combined proactive supplier engagement, scenario planning, and iterative design reviews to absorb tariff-related impacts while preserving product timelines and clinical integrity.

Actionable segmentation insights linking valve types, application niches, actuation modes, end-user settings, and flow rate classes to clinical performance

A segmentation-centric view clarifies how design intent, clinical context, and end-user environment shape technical and commercial decisions for proportional valves. Based on valve type, design teams commonly differentiate among flow control, pressure reducing, and pressure relief valves, each carrying distinct performance priorities such as linearity, response time, and overpressure behavior. These functional differences influence materials choice, control algorithm complexity, and validation protocols, and they determine the kinds of failure modes that must be mitigated in clinical settings.

Based on application, proportional valve selection is shaped by use-case specifics including infusion pumps, patient monitoring systems, surgical robots, and ventilators. Infusion pump contexts further require attention to syringe versus volumetric platforms, each with unique flow dynamics and contamination control considerations. Patient monitoring applications split into invasive and non-invasive modalities, which impose divergent requirements on sterilizability and interface integrity. Ventilator usage is differentiated by ICU and portable deployments, prompting different trade-offs between peak flow capabilities, energy consumption, and ruggedization.

Based on actuation type, the landscape bifurcates into electric actuation and pneumatic actuation, a choice that affects power management, control latency, and mechanical complexity. Based on end user, deployment environments span clinics, home healthcare, and hospitals, with clinics divided into general practice and specialty settings and hospitals categorized as private or public; each environment drives distinct procurement cycles, service models, and lifecycle expectations. Based on flow rate, technical requirements map to categories such as 0-100 L/min, 100-500 L/min, and above 500 L/min, which influence valve sizing, thermal management, and throughput testing. By viewing these segments in concert, decision-makers can align component selection, validation resources, and commercial strategies with the clinical and operational realities they intend to serve.

Regional dynamics and priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific driving distribution choices and regulatory alignment

Regional dynamics exert a powerful influence over regulatory timing, supplier ecosystems, and clinical adoption pathways for proportional valves. In the Americas, procurement cycles often prioritize supply resilience, clinical evidence packages, and transactional transparency; this environment favors suppliers that can demonstrate robust quality systems, responsive technical support, and reliable logistics. Meanwhile, Europe, Middle East & Africa typically demands stringent conformity with regional regulatory frameworks and harmonized technical documentation, driving suppliers to maintain comprehensive compliance records and to invest in post-market surveillance capabilities.

Asia-Pacific presents a heterogeneous environment in which rapid clinical adoption in certain markets coexists with diverse regulatory regimes and manufacturing ecosystems. The region often offers advanced manufacturing capabilities and specialized suppliers, which can accelerate innovation cycles but require careful qualification to ensure consistent global compliance. Distribution strategies must therefore be tailored to regional reimbursement structures, hospital procurement behaviors, and local service expectations.

Across all regions, successful commercialization depends on aligning product design with local clinical practices and regulatory expectations, investing in regionally appropriate training and support, and structuring supply chain redundancy that reflects geopolitical and tariff-related exposures. Coordinated regional strategies that recognize these differences will better position manufacturers to capture clinical acceptance and operational reliability across jurisdictions.

Competitive intelligence on leading proportional valve developers emphasizing product differentiation, supply resilience, strategic partnerships, lifecycle support

Competitive dynamics among companies that develop or integrate proportional valves hinge on the ability to combine technical differentiation with operational reliability and scalable support. Leading developers emphasize precision control, low-power actuation options, and validated materials that support sterilization and biocompatibility requirements. Equally important is the readiness of suppliers to provide detailed technical data packages, software interfaces, and long-term lifecycle support, which ease integration burdens for OEMs and reduce regulatory friction.

Supply resilience is a decisive commercial attribute; companies that have invested in diversified sourcing, inventory visibility, and production redundancy tend to better withstand logistical and policy shocks. Strategic partnerships and co-development agreements between valve specialists and device OEMs are increasingly common, as they enable earlier alignment on interfaces, testing regimes, and shared validation data. Additionally, companies that offer configurable platforms with modular control electronics and standardized communication protocols gain traction by shortening time-to-integration and supporting iterative product improvements.

Service and aftermarket capabilities - including calibration support, field diagnostics, and component traceability - further distinguish competitors. Firms that combine robust product engineering with predictable delivery, responsive technical support, and transparent quality documentation earn preference from hospitals and clinics that must minimize downtime and maintain regulatory compliance. Investors and strategic buyers will therefore assess firms on both innovation and operational execution.

Targeted operational, procurement, and R&D actions for medical device leaders to accelerate integration of proportional valve innovations into clinical products

Industry leaders must translate technical insight into concrete operational and strategic actions to secure clinical adoption and commercial resilience. First, align engineering specifications with the highest-priority clinical use cases by formalizing cross-functional requirement documents that incorporate input from clinicians, procurement, and quality assurance. This reduces late-stage redesign and accelerates validation. Second, implement dual-sourcing or qualified second-source strategies for critical components and validate alternatives early through expedited qualification protocols to reduce single-source exposure.

Third, invest in modular control architectures and standardized communication interfaces to simplify integration with device electronics and software ecosystems. This approach enables faster customization for different applications and eases regulatory change management. Fourth, strengthen supplier partnerships through co-development agreements that share validation responsibilities and create mutually aligned roadmaps, thereby reducing integration risk and improving time-to-deployment.

Fifth, embed post-market vigilance and remote diagnostics into valve offerings to provide customers with actionable performance data and reduce field-service burdens. Sixth, incorporate tariff scenario planning and cost-to-serve analyses into procurement cycles to manage policy-driven cost variability. Finally, prioritize training, documentation, and local support models that reflect regional regulatory and clinical practice differences so that deployment is smooth and adoption can scale across varied healthcare settings.

Robust mixed-method research approach combining technical validation, stakeholder interviews, and supply chain tracing to ensure accuracy and actionable insights

The research approach underpinning this analysis combined mixed methods to ensure technical rigor and practical relevance. Primary research included structured interviews with device engineers, clinical technologists, procurement leaders, and regulatory affairs professionals to capture real-world performance requirements, validation challenges, and procurement priorities. These interviews were supplemented by technical evaluations of representative valve architectures, including actuation mechanisms, control electronics, materials compatibility, and failure mode assessments.

Secondary research synthesized regulatory guidance, standards references, and publicly available technical documentation to contextualize design and compliance imperatives. Supply chain tracing and vendor capability mapping were employed to identify common concentrations of risk and to evaluate second-source feasibility. Patent landscape reviews and product literature analysis provided insight into differentiating innovations and common platform approaches.

Data triangulation and validation workshops ensured that findings reflected consensus across stakeholder groups and that technical assertions were tested against practical integration scenarios. Segmentation mapping linked functional requirements to end-user contexts and flow-rate classes, enabling prescriptive advice that aligns engineering choices with clinical and commercial constraints. This layered methodology provides a defensible foundation for decision-making while remaining adaptable to new technical or policy developments.

Synthesis of strategic imperatives and technological vectors that will guide procurement, development, and regulatory engagement for proportional valve adoption

The synthesis of technical, regulatory, and commercial perspectives reveals a convergent set of imperatives for proportional valve stakeholders. Precision control, reproducible performance under clinical conditions, and documented compliance form the core technical expectations that manufacturers and OEMs must meet. At the same time, supply resilience, modular integration capabilities, and post-market support determine the commercial viability of valve platforms in diverse healthcare environments.

Strategic responses that align design decisions with application-specific needs, validate alternative sourcing early, and invest in digital control and diagnostics will reduce integration risk and enhance clinical outcomes. Regional nuances in procurement behavior and regulatory frameworks necessitate tailored go-to-market approaches that respect local requirements while preserving global interoperability. Companies that combine product excellence with dependable delivery, transparent quality documentation, and proactive customer support will gain preferential access to hospital and clinic procurement decisions.

In short, successful adoption of proportional valve technologies requires coordinated action across engineering, quality, procurement, and clinical teams. When these functions work in tandem, organizations can convert technical capabilities into predictable clinical performance and operational continuity, thereby strengthening both patient outcomes and commercial positioning.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Proportional Valves for Medical Devices Market, by Valve Type

• 8.1. Flow Control
• 8.2. Pressure Reducing
• 8.3. Pressure Relief

9. Proportional Valves for Medical Devices Market, by Actuation Type

• 9.1. Electric Actuation
• 9.2. Pneumatic Actuation

10. Proportional Valves for Medical Devices Market, by Flow Rate

• 10.1. 0-100 L/Min
• 10.2. 100-500 L/Min
• 10.3. Above 500 L/Min

11. Proportional Valves for Medical Devices Market, by Application

• 11.1. Infusion Pumps
  • 11.1.1. Syringe
  • 11.1.2. Volumetric
• 11.2. Patient Monitoring
  • 11.2.1. Invasive
  • 11.2.2. Non-Invasive
• 11.3. Surgical Robots
• 11.4. Ventilators
  • 11.4.1. Icu
  • 11.4.2. Portable

12. Proportional Valves for Medical Devices Market, by End User

• 12.1. Clinics
  • 12.1.1. General Practice
  • 12.1.2. Specialty
• 12.2. Home Healthcare
• 12.3. Hospitals
  • 12.3.1. Private
  • 12.3.2. Public

13. Proportional Valves for Medical Devices Market, by Region

• 13.1. Americas
  • 13.1.1. North America
  • 13.1.2. Latin America
• 13.2. Europe, Middle East & Africa
  • 13.2.1. Europe
  • 13.2.2. Middle East
  • 13.2.3. Africa
• 13.3. Asia-Pacific

14. Proportional Valves for Medical Devices Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Proportional Valves for Medical Devices Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. United States Proportional Valves for Medical Devices Market

17. China Proportional Valves for Medical Devices Market

18. Competitive Landscape

• 18.1. Market Concentration Analysis, 2025
  • 18.1.1. Concentration Ratio (CR)
  • 18.1.2. Herfindahl Hirschman Index (HHI)
• 18.2. Recent Developments & Impact Analysis, 2025
• 18.3. Product Portfolio Analysis, 2025
• 18.4. Benchmarking Analysis, 2025
• 18.5. Beko Technologies A.S.
• 18.6. Bosch Rexroth AG
• 18.7. Burkert Werke GmbH & Co. KG
• 18.8. Danfoss A/S
• 18.9. Eaton Corporation plc
• 18.10. Emerson Electric Co.
• 18.11. Festo SE & Co. KG
• 18.12. IMI PLC
• 18.13. Moog Inc.
• 18.14. Parker Hannifin Corporation
• 18.15. Siemens Healthineers AG
• 18.16. SMC Corporation

LIST OF FIGURES

• FIGURE 1. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2025
• FIGURE 3. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
• FIGURE 4. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 5. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 7. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 9. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 11. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 12. UNITED STATES PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 13. CHINA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

• TABLE 1. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 2. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 3. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW CONTROL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 4. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW CONTROL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 5. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 6. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PRESSURE REDUCING, BY REGION, 2018-2032 (USD MILLION)
• TABLE 7. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PRESSURE REDUCING, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 8. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PRESSURE REDUCING, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 9. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PRESSURE RELIEF, BY REGION, 2018-2032 (USD MILLION)
• TABLE 10. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PRESSURE RELIEF, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 11. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PRESSURE RELIEF, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 12. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 13. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ELECTRIC ACTUATION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 14. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ELECTRIC ACTUATION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 15. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ELECTRIC ACTUATION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 16. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PNEUMATIC ACTUATION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 17. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PNEUMATIC ACTUATION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 18. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PNEUMATIC ACTUATION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 19. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 20. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY 0-100 L/MIN, BY REGION, 2018-2032 (USD MILLION)
• TABLE 21. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY 0-100 L/MIN, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 22. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY 0-100 L/MIN, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 23. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY 100-500 L/MIN, BY REGION, 2018-2032 (USD MILLION)
• TABLE 24. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY 100-500 L/MIN, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 25. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY 100-500 L/MIN, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 26. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ABOVE 500 L/MIN, BY REGION, 2018-2032 (USD MILLION)
• TABLE 27. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ABOVE 500 L/MIN, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 28. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ABOVE 500 L/MIN, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 29. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 30. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 31. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 32. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 33. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 34. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY SYRINGE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 35. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY SYRINGE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 36. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY SYRINGE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 37. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VOLUMETRIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 38. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VOLUMETRIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 39. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VOLUMETRIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 40. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2018-2032 (USD MILLION)
• TABLE 41. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 42. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 43. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 44. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 45. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 46. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 47. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY NON-INVASIVE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 48. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY NON-INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 49. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY NON-INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 50. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY SURGICAL ROBOTS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 51. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY SURGICAL ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 52. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY SURGICAL ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 53. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 54. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 55. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 56. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 57. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ICU, BY REGION, 2018-2032 (USD MILLION)
• TABLE 58. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ICU, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 59. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ICU, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 60. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 61. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 62. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 63. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 64. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 65. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 66. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 67. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 68. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY GENERAL PRACTICE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 69. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY GENERAL PRACTICE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 70. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY GENERAL PRACTICE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 71. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY SPECIALTY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 72. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY SPECIALTY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 73. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY SPECIALTY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 74. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 75. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 76. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 77. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 78. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 79. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 80. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 81. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 82. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 83. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 84. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 85. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 86. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 87. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 88. AMERICAS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 89. AMERICAS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 90. AMERICAS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 91. AMERICAS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 92. AMERICAS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 93. AMERICAS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 94. AMERICAS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 95. AMERICAS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 96. AMERICAS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 97. AMERICAS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 98. AMERICAS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 99. NORTH AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 100. NORTH AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 101. NORTH AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 102. NORTH AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 103. NORTH AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 104. NORTH AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 105. NORTH AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 106. NORTH AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 107. NORTH AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 108. NORTH AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 109. NORTH AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 110. LATIN AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 111. LATIN AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 112. LATIN AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 113. LATIN AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 114. LATIN AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 115. LATIN AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 116. LATIN AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 117. LATIN AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 118. LATIN AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 119. LATIN AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 120. LATIN AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 121. EUROPE, MIDDLE EAST & AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 122. EUROPE, MIDDLE EAST & AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 132. EUROPE PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 133. EUROPE PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 134. EUROPE PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 135. EUROPE PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 136. EUROPE PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 137. EUROPE PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 138. EUROPE PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 139. EUROPE PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 140. EUROPE PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 141. EUROPE PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 142. EUROPE PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 143. MIDDLE EAST PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 144. MIDDLE EAST PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 145. MIDDLE EAST PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 146. MIDDLE EAST PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 147. MIDDLE EAST PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 148. MIDDLE EAST PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 149. MIDDLE EAST PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 150. MIDDLE EAST PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 151. MIDDLE EAST PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 152. MIDDLE EAST PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 153. MIDDLE EAST PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 154. AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 155. AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 156. AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 157. AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 158. AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 159. AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 160. AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 161. AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 162. AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 163. AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 164. AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 165. ASIA-PACIFIC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 166. ASIA-PACIFIC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 167. ASIA-PACIFIC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 168. ASIA-PACIFIC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 169. ASIA-PACIFIC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 170. ASIA-PACIFIC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 171. ASIA-PACIFIC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 172. ASIA-PACIFIC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 173. ASIA-PACIFIC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 174. ASIA-PACIFIC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 175. ASIA-PACIFIC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 176. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 177. ASEAN PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 178. ASEAN PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 179. ASEAN PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 180. ASEAN PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 181. ASEAN PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 182. ASEAN PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 183. ASEAN PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 184. ASEAN PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 185. ASEAN PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 186. ASEAN PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 187. ASEAN PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 188. GCC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 189. GCC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 190. GCC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 191. GCC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 192. GCC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 193. GCC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 194. GCC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 195. GCC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 196. GCC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 197. GCC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 198. GCC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 199. EUROPEAN UNION PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 200. EUROPEAN UNION PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 201. EUROPEAN UNION PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 202. EUROPEAN UNION PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 203. EUROPEAN UNION PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 204. EUROPEAN UNION PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 205. EUROPEAN UNION PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 206. EUROPEAN UNION PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 207. EUROPEAN UNION PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 208. EUROPEAN UNION PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 209. EUROPEAN UNION PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 210. BRICS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 211. BRICS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 212. BRICS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 213. BRICS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 214. BRICS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 215. BRICS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 216. BRICS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 217. BRICS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 218. BRICS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 219. BRICS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 220. BRICS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 221. G7 PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 222. G7 PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 223. G7 PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 224. G7 PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 225. G7 PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 226. G7 PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 227. G7 PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 228. G7 PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 229. G7 PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 230. G7 PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 231. G7 PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 232. NATO PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 233. NATO PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 234. NATO PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 235. NATO PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 236. NATO PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 237. NATO PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 238. NATO PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 239. NATO PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 240. NATO PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 241. NATO PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 242. NATO PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 243. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 244. UNITED STATES PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 245. UNITED STATES PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 246. UNITED STATES PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 247. UNITED STATES PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 248. UNITED STATES PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 249. UNITED STATES PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 250. UNITED STATES PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 251. UNITED STATES PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 252. UNITED STATES PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 253. UNITED STATES PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 254. UNITED STATES PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 255. CHINA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 256. CHINA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 257. CHINA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 258. CHINA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 259. CHINA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 260. CHINA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 261. CHINA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 262. CHINA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 263. CHINA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 264. CHINA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 265. CHINA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)